Evidence map›Paper›PMID 39125439›Full record

ReviewNutrients2024

Nutritional Management and Physical Activity in the Treatment of Sarcopenic Obesity: A Review of the Literature.

Yavor Assyov, Iveta Nedeva, Borian Spassov, Antonina Gerganova, Toni Velikov, Zdravko Kamenov, Tsvetelina Velikova

Abstract readReview
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yavor AssyovDepartment of Internal Medicine, Clinic of Endocrinology, University Hospital "Alexandrovska" Medical University, Georgi Sofiyski 1 Str., 1431 Sofia, Bulgaria.
Iveta NedevaDepartment of Epidemiology and Hygiene, Medical University of Sofia, 1431 Sofia, Bulgaria.
Borian SpassovDepartment of Diagnostic Imaging, Medical University, 1431 Sofia, Bulgaria.
Antonina GerganovaDepartment of Internal Medicine, Clinic of Endocrinology, University Hospital "Alexandrovska" Medical University, Georgi Sofiyski 1 Str., 1431 Sofia, Bulgaria.
Toni VelikovClinic of Cardiology, SHATC "Medica Cor" EAD, 7000 Rousse, Bulgaria.
Zdravko KamenovDepartment of Internal Medicine, Clinic of Endocrinology, University Hospital "Alexandrovska" Medical University, Georgi Sofiyski 1 Str., 1431 Sofia, Bulgaria.ORCID 0000-0002-4829-9449
Tsvetelina VelikovaMedical Faculty, Sofia University St. Kliment Ohridski, 1407 Sofia, Bulgaria.ORCID 0000-0002-0593-1272

Funding

the Bulgarian National Science Fund . [Research Grant N KΠ-06-M43/3/2020]the European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, project No BG-RRP-2.004-0008.
6 · The paper itself

Abstract

backgroundThe prevalence of sarcopenic obesity among adults aged ≥65 years is increasing worldwide. It is a condition that describes the concomitant presence of sarcopenia and obesity, but it appears to be associated with greater increases in the risks for disability, morbidity, and mortality than the two conditions combined. The current review aims to summarize the available literature data on the effectiveness of lifestyle modification for the management of this high-risk geriatric syndrome.

methodsWe conducted a comprehensive search across multiple databases, including PubMed, Scopus, Web of Science, and Cochrane Library, for publications published from January 1950 to June 2024.

resultsThe detection of early preventive and therapeutic approaches to combat sarcopenic obesity is essential for healthy aging. There is ample evidence that suggests that poor dietary habits and physical inactivity are the main reasons for the development of sarcopenic obesity and should thus be the main targets for intervention. In the absence of effective pharmacological interventions, the best effect on sarcopenic obesity is achieved by combination with proper dietary intervention and regular physical activity according to the individual's health condition.

conclusionsFurther research is needed to discover the most effective strategy for the prevention and treatment of sarcopenic obesity, as well as potential pharmacological options to improve muscle mass and function in older populations with physical restrictions.

Indexed as

ExerciseObesitySarcopeniaAgedAged, 80 and overFemaleHumansMaleNutritional Statuselderlyinterventionnutritional managementobesityresistance trainingsarcopeniasarcopenic obesity

Identifiers

PMID39125439
PMCPMC11314398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.